key: cord-0744843-yn7hkji5 authors: Goytan, Annemarie; Lee, William; Dong, Huiru; Hayashi, Kanna; Milloy, M. J.; Kerr, Thomas title: The impact of PSTD on service access among people who use drugs in Vancouver, Canada date: 2021-06-26 journal: Subst Abuse Treat Prev Policy DOI: 10.1186/s13011-021-00390-x sha: dbc0062f6a2bf9a5e17c239b10cae7854314f52d doc_id: 744843 cord_uid: yn7hkji5 BACKGROUND: Settings throughout the United States and Canada are contending with high rates of drug-related overdose. This in turn has prompted efforts to more effectively engage people who use drugs (PWUD) in treatment and care. However, while co-morbid mental disorders are prevalent among PWUD and can undermine access to services, the impact of post-traumatic stress disorder (PTSD) on service access is not known. Therefore, we sought to assess whether PTSD is associated with difficulties accessing health and social services among PWUD in Vancouver, Canada. METHODS: Survey data was derived from two prospective cohorts of PWUD in Vancouver, Canada for the period of April 2017 to November 2018. PTSD was assessed using the PTSD Checklist for the DSM-V (PCL-5). Generalized estimating equations (GEE) was used to estimate the relationship between PTSD and self-reported inability to access health and social services, after adjustment for confounders. RESULTS: Among 810 participants included in our analysis, 316 (39.0%) participants qualified for a provisional PSTD diagnosis, and 117 (14.4%) reported difficulties accessing services. In a multivariable GEE analysis, a PTSD diagnosis (adjusted odds ratio = 1.69, 95% confidence interval: 1.12–2.55) was independently associated with difficulties accessing services. CONCLUSIONS: We found high rates of PTSD and self-reported difficulties accessing services among PWUD in Vancouver, as well as a positive association between PTSD and difficulties with service access. These findings highlight the need for trauma-informed approaches to service delivery for PWUD, as well as enhanced provider training specific to PTSD. Settings throughout the United States and Canada continue to experience unprecedented levels of opioid overdoses driven largely by the increasing presence of synthetic fentanyl and related substances. This is true of Vancouver, British Columbia (BC), Canada, where in 2016 a public health emergency was declared in response to a rapid increase in overdose deaths; an 87% increase from 529 deaths in 2015 to 991 in 2016 [2] . Despite the existence of a range of harm reduction and treatment programs, estimated to have reduced total overdose fatalities from 1547 in 2018 to 983 in 2019, overdose rates remain high. The continued high overdose rate may be attributed in part to the stigma surrounding substance use, which creates a major barrier to accessing overdose prevention services and treatment programs [1, 22] . The crisis continues to worsen during the COVID-19 pandemic as 1068 overdose fatalities were recorded in the first 8 months of 2020 alone [2] . Comorbid mental disorders are prevalent among people who use drugs (PWUD) and are known to be associated with suboptimal health and social service access, poor treatment retention and outcomes, as well as elevated overdose risk [3, 9, 10, 20] . Among Canadians with a mental health disorder, those with a substance use disorder were over three times more likely than those without a substance use disorder to experience unmet mental health care needs [23] . Of particular concern is the high rate of post-traumatic stress disorder (PTSD) among PWUD. While the lifetime prevalence of PTSD in the general Canadian population is approximately 9.2% [24] , the lifetime prevalence of PTSD among those with a substance use disorder is estimated to be between 26 and 52% [20] . PTSD is characterized by intrusions, avoidance behaviour, changes in mood and hypervigilance [8] , all of which can impair goal-oriented thinking and behaviour, like pursuing supportive services and staying connected to services [17] . Additionally, recent data has indicated that a PTSD diagnosis almost doubles the overdose risk among people who use opioids [17] . Furthermore, many providers are untrained in trauma informed care (TIC), especially caring for PWUD [3] , and can administer inappropriate care and perpetuate substance use related stigma, deterring PWUD from approaching services. While the ongoing overdose crisis has prompted efforts to improve access to health and social services and promote addiction treatment engagement [14] , multiple factors can create service access barriers for PWUD with a PTSD diagnosis, heightening risks of poor treatment retention, outcomes and overdose death. While access to services for PWUD with varying secondary mental health diagnoses like major depressive disorder (MDD) [3] , anxiety disorder [15] , and other psychiatric conditions [6] have been well investigated, the impact of PTSD on PWUD's service access has not been well characterized. Therefore, we sought to explore the relationship between PTSD and difficulties accessing health and social services among PWUD in Vancouver. Data were derived and combined from two ongoing and harmonized prospective cohort studies of PWUD in Vancouver, Canada: the Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS). Both cohorts have been recruited via snowball sampling, self-referral and street outreach since 1996 and have been described in detail elsewhere [21, 27] . In short, VIDUS eligible participants are HIV-negative individuals who have injected illicit drugs at least once in the month prior to enrolment. ACCESS eligible participants are HIV-positive individuals who used illicit drugs other than or in addition to cannabis in the month prior to enrolment. At baseline and semiannually, both VIDUS and ACCESS participants complete a harmonized interviewer-administered questionnaire which gathers quantitative information on demographic characteristics, substance use and risk behaviours, drug use treatment and use of health services information. Participants from each cohort also provide a venous blood sample for serologic testing. All participants provide informed consent and are given a $40 (CAD) stipend after each study visit. The use of VIDUS and ACCESS data in the current study have been approved by the University of British Columbia's Research Ethics Board. Our analyses are restricted to VIDUS and ACCESS participants who completed at least two study interviews at two distinct time points between April 2017 and November 2018. The primary outcome of interest was the inability to access services, assessed by the question: "in the last 6 months, was there a time you were in need of a service (e.g., housing, counselling, police) but could not obtain it?". This definition has been used in previous studies [19, 25] to assess service access barriers among PWUD and was coded dichotomously (yes vs. no). To assess for PTSD, each participant completed the PTSD Checklist for DSM-5 (PCL-5). This 20-item questionnaire evaluates PTSD symptoms experienced in the previous month. Each item is answered on a five-point scale (zero = not at all to four = extremely), and scores range from 0 to 80. Consistent with previous studies, a provisional PTSD diagnosis was defined as a PCL-5 score of 31 or higher [26] . After reviewing the literature [3, 17, 19] , other characteristics considered as potential confounders included age (≥median vs.